Cannabidiol

Overview

Cannabidiol is a phytocannabinoid derived from the cannabis plant that does not induce psychoactive effects. It is primarily used to treat certain forms of epilepsy and is being investigated for its potential to alleviate various conditions involving pain and inflammation.

API suppliers (16)

Suppliers of Cannabidiol evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• YUNNAN HANSU BIOTECHNOLOGY CO LTDChina2 active DMF
• DIVISION OF THERAPEUTICS AND MEDICAL CONSEQUENCES1 active DMF
• THC PHARM GMBHGermany1 active DMF
• VERANOVA LPUnited Kingdom1 active DMF
• FARMABIOS SPAItaly1 active DMF
• SCI PHARMTECH INCTaiwan1 active DMF
• AGNO PHARMA USAChina1 active DMF
• Medipharm Labs IncCanada1 active DMF GMP on record
• INDENA SPAItaly1 active DMF GMP on record
• Alkem Laboratories LimitedIndia1 active DMF GMP on record
• AVERIX BIOUnited States1 active DMF
• LUPIN MANUFACTURING SOLUTIONS LTD1 active DMF
• ROLABO OUTSOURCING SLSpain1 active DMF GMP on record
• MSN LIFE SCIENCES PRIVATE LIMITEDIndia1 active DMF GMP on record
• BENUVIA OPERATIONS LLC1 active DMF
• BIOPHORE INDIA PHARMACEUTICALS PVT LTD1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Cannabidiol expires 1 Mar 2041 and exclusivity 31 Jul 2027. Generic API sourcing typically opens up once these lapse.

Therapeutic areas